In summary, through SOX4/ChREBP axis, we effectively explained the reason for SOX4 altering the levels of various fatty acid metabolism genes in HCC, thereby regulating fatty acid metabolism reprogramming. The gene discussed is MLXIPL; the disease is hepatocellular carcinoma.